Evidence map›Paper›PMID 28718494›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2016

The HIV care cascade in Buenos Aires, Argentina: results in a tertiary referral hospital.

Carina Cesar, Gabriela Blugerman, José Antonio Valiente, Peter Rebeiro, Omar Sued, Valeria Fink, Mariana Romero Soto, Roberto Cillis, Cleyton Yamamoto, Carlos Falistocco and 2 more

Abstract read
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carina CesarFundación Huésped, Investigaciones Clínicas, Buenos Aires, Argentina.
Gabriela BlugermanHospital General de Agudos Juan A. Fernández, Infectología, Buenos Aires, Argentina.
José Antonio ValienteHospital General de Agudos Juan A. Fernández, Infectología, Buenos Aires, Argentina.
Peter RebeiroVanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Omar SuedFundación Huésped, Investigaciones Clínicas, Buenos Aires, Argentina.
Valeria FinkFundación Huésped, Investigaciones Clínicas, Buenos Aires, Argentina.
Mariana Romero SotoHospital General de Agudos Juan A. Fernández, Farmacia, Buenos Aires, Argentina.
Roberto CillisHospital General de Agudos Juan A. Fernández, Farmacia, Buenos Aires, Argentina.
Cleyton YamamotoFundación Huésped, Investigaciones Clínicas, Buenos Aires, Argentina.
Carlos FalistoccoDirección de Sida y ETS, Ministerio de Salud, Buenos Aires, Argentina.
Pedro CahnFundación Huésped, Investigaciones Clínicas, Buenos Aires, Argentina.
Héctor PérezHospital General de Agudos Juan A. Fernández, Infectología, Buenos Aires, Argentina.

Funding

CCASAnet: Caribbean, Central and South America NetworkU01AI069923 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pedro Enrique Cahn, Jessica L Castilho · 2006 to 2026
$41.6M
NIAID NIH HHS U01 AI069923
6 · The paper itself

Abstract

objectiveTo determine rates of retention, antiretroviral therapy (ART) use, and viral suppression in an adult cohort from a public tertiary referral hospital in the city of Buenos Aires, Argentina.

methodsHIV-positive ART-naïve patients ≥ 18 years old starting care 2011-2013 contributed data until the end of 2014. Three outcomes were assessed in 2014: retention in care, ART use, and viral suppression. Patient characteristics associated with each outcome were assessed through logistic regression.

resultsA total of 1 031 patients were included. By the end of 2014, 1.5% had died and 14.8% were transferred to a different center. Of the remaining 859 patients, 563 (65.5%) were retained in 2014. Among those retained, 459 (81.5%) were on ART in 2014. Of those 459 on ART, 270 (58.8%) were virologically suppressed. Younger age was associated with lower retention (OR (odds ratio): 0.67; 95% CI (confidence interval): 0.44-0.92 for ≥ 35 vs. < 35 years), but unrelated with ART use or viral suppression. Low CD4 count at first visit was associated with ART use (OR: 35.72 for CD4 < 200, 7.13 for CD4 200-499 vs. ≥ 500, P < 0.001) and with virologic suppression (OR: 2.17 for CD4 < 200, 2.46 for CD4 200-499 vs. ≥ 500, P: 0.023).

conclusionsOur hospital in Buenos Aires is still below the recommended 90-90-90 targets of the Joint United Nations Programme on HIV/AIDS (UNAIDS) for ART use and viral suppression. We found a major gap in retention in care. Identifying younger age as being associated with worse retention will help in the design of targeted interventions.

Indexed as

Viral LoadAdultAnti-HIV AgentsArgentinaCD4 Lymphocyte CountHIV InfectionsHumansPatient ComplianceRegression AnalysisTertiary Care CentersAnti-HIV Agents

Identifiers

PMID28718494
PMCPMC5518480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.